ConductScience.org, home

Paper7214366

Effects of tamoxifen on estrogen and progesterone receptors in human breast cancer.

Waseda N and 3 others. Cancer Res, 1981. Cited by 63 papers, by iCite.

Cite this record

ConductScience Library. Effects of tamoxifen on estrogen and progesterone receptors in human breast cancer. Papers, record 7214366. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/7214366

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Effects of tamoxifen on estrogen and progesterone receptors in human breast cancer.
PubMed
Journal
Cancer Res
PubMed
Year
1981
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
63
iCite
Relative citation ratio, by iCite
2.78
iCite
Revised in PubMed
2013-11-21
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Waseda NN
2Kato YY
3Imura HH
4Kurata MM

Source PubMed

Download CSV of authors

Topics10

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Breast NeoplasmsMajor topic
Receptors, EstrogenMajor topic
Receptors, ProgesteroneMajor topic
TamoxifenMajor topic
Cell Nucleus
Cytosol
Humans
Kinetics
Temperature
Time Factors

Source PubMed

Download CSV of topics

Cited by15

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 63 citations.

PMIDTitleJournalYearIn PapersSource
41386485The effects of tamoxifen and its metabolites on circulating estrogen metabolites among pre- and postmenopausal women.Steroids2026https://conductscience.org/library/papers/41386485PubMed
28134770Review: Receptor Targeted Nuclear Imaging of Breast Cancer.Int J Mol Sci2017https://conductscience.org/library/papers/28134770PubMed
22331216Assessment of progesterone receptors in breast carcinoma by PET with 21-18F-fluoro-16α,17α-[(R)-(1'-α-furylmethylidene)dioxy]-19-norpregn-4-ene-3,20-dione.J Nucl Med2012https://conductscience.org/library/papers/22331216PubMed
9635844The effect of 3-week tamoxifen treatment on oestrogen receptor levels in primary breast tumours: a flow cytometric study.Br J Cancer1998https://conductscience.org/library/papers/9635844PubMed
8750530Cell cycle expression of steroid receptors determined by image analysis on human breast cancer cell line: a hypothesis on the effects of antiestrogens.Breast Cancer Res Treat1996https://conductscience.org/library/papers/8750530PubMed
8611373Variation of hormonal receptor, pS2, c-erbB-2 and GSTpi contents in breast carcinomas under tamoxifen: a study of 74 cases.Br J Cancer1996https://conductscience.org/library/papers/8611373PubMed
8554983Oestrogen receptor: a stable phenotype in breast cancer.Br J Cancer1996https://conductscience.org/library/papers/8554983PubMed
8491762Immuno-biochemical assay for determination of nuclear steroid receptors during tamoxifen therapy.J Cancer Res Clin Oncol1993https://conductscience.org/library/papers/8491762PubMed
8251648Measurement of steroid hormone receptors in breast cancer patients on tamoxifen.Breast Cancer Res Treat1993https://conductscience.org/library/papers/8251648PubMed
8250600Effects of tamoxifen on human breast cancer cells in vitro.Arch Gynecol Obstet1993https://conductscience.org/library/papers/8250600PubMed
7171839Variability of steroid receptors in multiple biopsies of breast cancer: effect of systemic therapy.Breast Cancer Res Treat1982https://conductscience.org/library/papers/7171839PubMed
3437623A study on the correlation between estrogen receptor, progesterone receptor and tamoxifen binding sites in human breast cancer tissues.Jpn J Surg1987https://conductscience.org/library/papers/3437623PubMed
2931228The oestrogen antagonists, tamoxifen and FC-1157a, display oestrogen like effects on human lymphocyte functions in vitro.Clin Exp Immunol1985https://conductscience.org/library/papers/2931228PubMed
2151369Cyclical use of tamoxifen and high-dose medroxyprogesterone acetate in advanced estrogen receptor positive breast cancer.Breast Cancer Res Treat1990https://conductscience.org/library/papers/2151369PubMed
1756259Phase II evaluation of interferon added to tamoxifen in the treatment of metastatic breast cancer.Breast Cancer Res Treat1991https://conductscience.org/library/papers/1756259PubMed

Download CSV of cited by

Genes2

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
ESR12099PubTator's text mininghttps://conductscience.org/library/genes/2099NCBI Gene
PGR5241PubTator's text mininghttps://conductscience.org/library/genes/5241NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/7214366

GET https://conductscience.org/api/papers/v1/7214366/authors